In summary, this study demonstrates that LOX could play a relevant role in the metabolic dysfunction induced by obesity and suggests that the inhibition of LOX activity could be a valuable strategy to ameliorate obesity-related metabolic disturbances. This evidence concerns the gene LOX and obesity due to melanocortin 4 receptor deficiency.